An Epigenetic Signature in Peripheral Blood Predicts Active Ovarian Cancer
Andrew E. Teschendorff, Usha Menon, Aleksandra Gentry-Maharaj et al. · 2009
Read An Epigenetic Signature in Peripheral Blood Predicts Active Ovarian Cancer by Andrew E. Teschendorff, Usha Menon, Aleksandra Gentry-Maharaj et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0008274.txt.
Description
Andrew E. Teschendorff and colleagues searched blood for ovarian cancer signals in PLOS ONE in 2009. DNA methylation marks in blood may flag epithelial cancers early. Such marks could serve for diagnosis or risk prediction. No large study had yet tested their potential for ovarian cancer. The team evaluated that potential in a large case-control study.
They found an epigenetic signature in peripheral blood linked to active ovarian cancer. A blood-based signature could catch a cancer that often hides until late. Early detection would greatly improve treatment chances. The study is a step toward a blood test for this disease.
Catalog record
| CREATOR | Andrew E. Teschendorff, Usha Menon, Aleksandra Gentry-Maharaj et al. |
|---|---|
| YEAR | 2009 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 53 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0008274